Kelly Thomas Patrick 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
Kelly Thomas Patrick
Chief Financial Officer
Transactions
- Award
Common Stock
2023-10-28+8,244→ 65,384 total - Sale
Common Stock
2023-10-30$12.02/sh−2,316$27,833→ 63,068 total
Footnotes (2)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 8,244 RSUs.
- [F2]This sale was to cover tax liabilities in the vesting of RSUs.